BEFORE DOWNLOADING, PRINTING OR VIEWING THIS PROSPECTUS, YOU MUST CAREFULLY READ THE TERMS SET OUT IN THIS NOTICE
HyGIeaCare, Inc. ARBN 619 947 983 (Company) lodged a Prospectus (Prospectus) on 24 August 2017 with the Australian Securities and Investment Commission (ASIC) in relation to the Company's proposed initial public offering and listing on the Australian Securities Exchange (ASX) of CHESS Depositary Interests (CDIs) (Offer). The Company lodged a Supplementary Prospectus with ASIC on 19 September 2017. The Prospectus and Supplementary Prospectus are available for download from this website, and a paper copy is available free of charge to any person in Australia by calling 1800 500 095 (within Australia) between 8:30am and 5:30pm Australian Eastern Standard Time (AEST).
Capitalised terms used on this website have the meanings given to them in the Prospectus.
The Prospectus is an important document and Applicants should read it in full and consider it in deciding whether to apply for CDIs. Offers of CDIs will only be made in, or accompanied by, a copy of the Prospectus. If after reading the Prospectus, you have questions about the Offer, you should contact your stockbroker, accountant or other professional adviser.
Applications to apply for CDIs under the Broker Firm Offer may only be made using an Application Form to be issued with, contained in, or accompanying, the Prospectus. The Broker Firm Offer opens on 5 September 2017 and is scheduled to close at 5pm (AEST) on 31 October 2017 but the Offer may be extended or closed early by the Company without prior notice. You must complete a valid Application Form if you want to apply for CDIs. CDIs will only be issued on the basis of a valid Application Form.
The Prospectus on this website is available to persons accessing the website from within Australia only. By accessing the Prospectus, you acknowledge and confirm that you are an Australian resident and are accessing the website from within Australia.
Neither the Prospectus nor anything on this website constitutes an offer of securities in the United States, or to any person outside Australia to whom it would not be lawful to make such an offer. The securities referred to in the Prospectus and on this website have not been, and will not be, registered under the US Securities Act or pursuant to the securities laws of any other jurisdiction outside Australia. Any securities described in, or sold pursuant to, the Prospectus may not be offered or sold in the United States except in transactions exempt from, or not subject to, registration under the US Securities Act and applicable U.S. state securities laws.
The Company will apply to ASX for admission of the Company to the official list and for quotation of its CDIs on ASX. None of ASIC, ASX or their officers take any responsibility for the contents of the Prospectus or for the merits of the investment to which the Prospectus relates.
The Company disclaims all liability, whether in negligence or otherwise, to persons who trade the CDIs before receiving their holding statement.
No CDIs will be issued on the basis of the Prospectus later than 13 months after the Prospectus Date.
NOT INVESTMENT ADVICE
The information on this website is provided for informational purposes only and subject to change without notice. The information in the Prospectus is not financial product advice and does not take into account your investment objectives, financial situation or particular needs.
It is important that you read the Prospectus carefully and in its entirety before deciding whether to invest in the Company. In particular, in considering the prospects of the Company, you should consider the basis of preparation and presentation of the Financial Information and the risk factors that could affect the Company's business, financial performance and operations. You should carefully consider this information in light of your personal circumstances (including financial and tax issues) and seek professional guidance from your stockbroker, solicitor, accountant or other independent professional adviser before deciding whether to invest in the Company.
Some of the key risk factors that should be considered by prospective investors are set out in Section 5 of the Prospectus. There may be risk factors in addition to these that should be considered in light of your personal circumstances.
No person named in the Prospectus, nor any other person, warrants or guarantees the performance of the Company or the repayment of capital or any return on investment made pursuant to the Prospectus.
The Prospectus includes information regarding past performance of the Company. Investors should be aware that past performance should not be relied upon as being indicative of future performance.
No person is authorised to give any information or to make any representation in connection with the Offer described in the Prospectus, which is not contained in the Prospectus. Any information not so contained may not be relied upon as having been authorised by the Company, the Directors or any other person in connection with the Offer. You should rely only on information in the Prospectus.
FORWARD LOOKING STATEMENTS
The Prospectus contains forward looking statements, which are statements which may be identified by words such as "may", "could", "believes", "estimates", "expects", "intends" and other similar words. These statements are based on an assessment of present economic and operating conditions and on a number of assumptions regarding future events and actions that, at the date of the Prospectus, are expected to take place. Such forward looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, the Directors and the Company’s management. The Company cannot and does not give any assurance that the results, performance or achievements expressed or implied by the forward looking statements contained in this Prospectus will actually occur and investors are cautioned not to place undue reliance on these forward looking statements.
The Corporations Act prohibits the Company from processing Applications in the seven day period after the date of lodgement of the Prospectus (Exposure Period). The Exposure Period enables the Prospectus to be examined by market participants prior to the raising of funds. Applications received during the Exposure Period will not be processed until after the expiry of the Exposure Period. No preference will be conferred on any Applications received during the Exposure Period.
Instructions on how to apply for CDIs are set out in Section 7 of the Prospectus and on the back of the Application Form. Alternatively, please contact the Company Offer information line on 1800 500 095 (within Australia) or +61 1800 500 095 (outside Australia) from 9.00am until 5.30pm (AEST) Monday to Friday (business days only).
If you have any questions about the investment constituted by this Offer, you should seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser.
THE PROSPECTUS IS IMPORTANT AND SHOULD BE READ IN ITS ENTIRETY
By clicking the 'I ACCEPT' button below and accessing the Prospectus on this website, you represent,
warrant and agree that:
The HyGIeaCare® System is an FDA cleared prescription medical device, approved only for colon cleansing, when medically indicated, such as before radiologic or endoscopic examinations.
© 2017 HyGIeaCare Inc. All rights reserved. HyGIeaCare logo are trademarked and are registered by HyGIeaCare Inc.